Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate hydrogel for chronic leg wounds
ACTRN12624001365550Phase 2Recruiting
- Sponsor
- Ego Pharmaceuticals
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Chronic wound comparing Mometasone furoate hydrogel with Placebo hydrogel (2 arms). Primary endpoints: Relative change from baseline in wound area, Relative change from baseline in MMP-8 in wound exudate and 2 more. Started Mar 2023; status: recruiting.
02
Drugs
mometasone
03
Conditions
Chronic wound
Beyond the preview
Go deeper on ACTRN12624001365550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001365550.